
YCBD-PA
US listing
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Mar 31, 2025
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 12, 2020 | Before the open | -0.04 | -0.17 | -325.0% |
| May 15, 2020 | After the close | -0.08 | 0.46 | +675.0% |
| Feb 13, 2020 | After the close | -0.15 | 0.45 | +400.0% |
| Dec 18, 2019 | After the close | -0.17 | 0.79 | +564.7% |
| Aug 14, 2019 | After the close | -0.10 | -1.19 | -1090.0% |
| May 15, 2019 | After the close | -0.05 | -3.13 | -6160.0% |
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, ready to drink cans, and sleep, focus, and calming aids. It also provides veterinarian-formulated products, including…